Senior Positions At Hoechst Marion Roussel

6 November 1995

Hoechst Marion Roussel has announced senior appointments. The company's North American senior management team is made up of:

- Richard Bailey, vice president human resources and corporate relations; - Gerald Belle, president Hoechst Marion Roussel Canada; - Edward Connolly, vice president community affairs; - Larry Downey, director of business management; - Richard Frankivoc, president Rugby Laboratories;- Jerry Hedrick, vice president government affairs; - William Hoskins, vice president and general counsel; - James Mitchum, vice president finance and administration; - Francois Nader, US medical director and vice president medical affairs; - Charlie Portwood, vice president operations; - Scott Ragland, vice president information systems; - Alban Schuele, vice president and chief financial officer; - Kirk Schueler, vice president US commercial director; - David Thompson, vice president communications; and - Elaine Waller, vice president US regulatory.

In addition, John Vandewalle is named chief executive of Teva/Marion Partners, and Jerry Harney becomes president of a newly-formed division within HMR that will provide information-based products and services.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight